Background: Living kidney transplantation comprises the majority of kidney transplantations in Japan. Living kidney donors should be assured of their own health. Therefore, Japanese guidelines define the criterion of kidney function for living donors. Glomerular filtration rates (GFR) ≥ 70 mL/min/1.73 m 2 are required for marginal donors. The guidelines require that GFRs of donors be measured by the inulin (In) clearance method (C In ) or the radioisotope method, but these methods can be substituted with the creatinine (Cr) clearance method (C Cr ). Methods for estimating kidney function are susceptible to error, and decision-making regarding donor eligibility could be affected by the estimation method used. We investigated the adequacy of decision-making based on kidney function estimation methods used in Japanese living kidney donor candidates by comparing C Cr or estimated GFR (eGFR), calculated by several equations, and C In as measured GFR (mGFR). Methods: In total, 210 people, including 36 actual kidney donor candidates, who had both C In and C Cr measured at Shinshu University Hospital from April 2011 to April 2015, were included. Cr and cystatin C (Cys) levels measured at the same time were used to calculate eGFR (eGFR Cr and sGFR Cys , respectively). We evaluated the concordance rates of cases whose GFR levels were ≥ 70 mL/min/1.73 m 2 in this study and assumed that they were living kidney donor candidates. Only kidney donor candidates underwent an additional sensitivity analysis. Results: Median C In and C Cr were 55.5 mL/min/1.73 m 2 and 68.0 mL/min/1.73 m 2 , respectively. C Cr had the highest tendency to overestimate kidney function. Some participants were incorrectly evaluated as adequate using C Cr , despite their mGFR being inadequate for living kidney donors according to the guidelines. These results were independent of sex or actual living kidney donor candidates. The average of eGFR Cr and eGFR Cys was well correlated with C In .
Background
The number of patients with end-stage kidney disease has been rising, and the number of patients who require kidney transplantation has also been increasing worldwide. Living kidney transplantation comprises the majority of kidney transplantations in Japan because of a lack of cadaveric kidney donors [1] . It is important that the kidney donor be assured of their own health before they are willing to donate a kidney. In particular, they need to be assured that they will not suffer kidney failure after they donate. Therefore, committees of each country performing kidney transplantation have established guidelines for living kidney donors.
The Japanese guidelines for living kidney donation define the criterion of adequate kidney function for the donor as a glomerular filtration rate (GFR) ≥ 80 mL/ min/1.73 m 2 [2] . If the donor candidate has a lower function than the criterion, a GFR ≥ 70 mL/min/1.73 m 2 is allowed as a marginal donor according to the guidelines. Moreover, the guidelines require that the donor candidate GFR be measured by the inulin clearance method (C In ) or the radioisotope method but the creatinine clearance method (C Cr ) can be substituted [2] . Which method to adopt depends on each kidney transplant center in these circumstances. However, C Cr is known to overestimate kidney function among subjects with decreased GFR because creatinine (Cr) can be secreted by renal tubular cells. Therefore, the Consensus Statement of the Amsterdam Forum on the Care of the Live Kidney Donor states that C Cr may under or overestimate GFR in patients with normal or near normal kidney function [3] .
Other GFR estimation methods based on the estimation formula (eGFR) are simple and widely used but less accurate. An eGFR calculated using the Japanese equation for estimated GFR (eGFR Cr ) has a standard that 75% of the subjects tested fall within ± 30% of the real GFR [4] . Furthermore, eGFR Cr is susceptible to error. Although GFR estimation methods other than eGFR Cr exist, differences among these methods and their potential impact regarding donor eligibility testing is not well known. Though C In is a gold standard method for estimating GFR, it is a challenge because of the required reagent preparation and the need for multiple blood and urine samples. Therefore, only a limited number of facilities conduct C In testing routinely.
Estimation methods for kidney function of living kidney donor candidates are potentially susceptible to error, and the decision-making regarding donor eligibility could be affected by the estimation method used. But the impact of these differences is not thoroughly known. In addition to this, there is no uniformity as different evaluation methods are used at each transplantation center. The evaluation of donor eligibility may not be a unified standard in Japan for these reasons. We conducted this study to investigate the adequacy of decisionmaking based on each kidney function estimation method for Japanese living kidney donor candidates through the comparison of C Cr or eGFR from several equations and C In as measured GFR (mGFR).
Methods

Study design
This study was conducted as a single-center retrospective observational study. All subjects who had both their C In and C Cr measured within a 3-day period from April 2011 to April 2015 were included. The data of 210 participants were extracted for this study, which included 36 actual living kidney donor candidates. All 210 participants were included to detect differences between C In and several GFR estimation methods, because using only actual living kidney donor candidates was insufficient for statistical analysis. To verify whether the results obtained from the analysis of all 210 participants could apply to living kidney donor candidates, we performed a sensitivity analysis limited to actual living kidney donor candidates. Participants' characteristics and laboratory data were located and extracted from the medical records at Shinshu University Hospital. This study protocol was approved by the Shinshu University Ethical Committee (approval number 3384) and was conducted in accordance with the principles of the Declaration of Helsinki, as revised in 2013.
Methods of measurement
Serum creatinine (Cr) was measured with an enzymatic method using a BM6070 auto biochemical analyzer (JEOL Ltd., Tokyo, Japan). The normal ranges of Cr at our institute were 0.65-1.07 mg/dL (males) and 0.46-0.79 mg/dL (females). Serum cystatin C (Cys) was measured with the latex immunoturbidimetric method using the same analyzer. The normal range of Cys at our institute was 0.60-0.98 mg/L. C Cr and eGFR were calculated using the following formula using Cr or Cys.
C In
C In was measured using the simple sampling strategy reported previously [5] . Subjects were asked to drink 500 mL water 15 min prior to infusion of inulin. A 1% inulin (Fuji Yakuhin Co. Saitama, Japan) containing saline infusion was started at the pace of 300 mL/ h. Thirty minutes after starting inulin administration, the pace of infusion was changed to 100 mL/h. Fortyfive minutes after inulin administration, subjects had to urinate completely to empty their bladder and hydrate with 180 mL water orally, after which a blood sample was collected. Blood and urine samples were collected 60 min later (105 min after starting inulin infusion). Measurements of plasma and urine inulin concentrations were performed using an enzymatic method. C In was calculated using the average of plasma inulin concentration at 45 min and 105 min, as well as urine inulin concentration and urine volume. C In was calculated per 1.73 m 2 body surface area to compare with other kidney function estimating tests as measured GFR. C In was finally calculated with the following formula. The eGFR was calculated using laboratory data collected at the time C Cr and C In were measured. We used the following formulas to calculate a Cr-based eGFR (eGFR Cr ) and a Cys-based eGFR (eGFR Cys ) [6, 7] . These formulas were targeted for Japanese adults and are used most widely in Japan. Female eGFR Cys = {104 × Cys −1.019 × 0.996 Age ×0.929} − 8 [7] In addition to these equations, the average of eGFR Cr and eGFR Cys (eGFR Cr+Cys ) was calculated and used for comparison, because it has been reported that eGFR Cr+Cys is more accurate [8] .
eGFR CrþCys ðmL= min=1:73 m 2 Þ ¼ eGFR−CrþeGFR−Cys 2 Moreover, we used another Cr-based GFR equation, The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation (eGFR-CKDEPI Cr ) in this study [9] . eGFR − CKDEPI Cr (mL/ min /1.73 m 2 ) Male; Cr ≤ 0:9 mg=dL; eGFR−CKDEPI Cr ¼ 141 Â ð Cr 0:9 Þ −0:411 Â 0:993 Age [9] Male; Cr > 0:9 mg=dL; eGFR−CKDEPI Cr ¼ 141 Â ð Cr 0:9 Þ −1:209 Â 0:993 Age [9] Female; Cr ≤ 0:7 mg=dL; eGFR−CKDEPI Cr ¼ 141 Â ð Cr 0:9 Þ −0:329 Â 0:993 Age [9] Female; Cr > 0:7 mg=dL; eGFR−CKDEPI Cr ¼ 141 Â ð Cr 0:9 Þ −1:209 Â 0:993 Age [9] All eGFR data were presented as mL/min/1.73 m 2 and used for comparison.
Outcome
We compared each kidney function estimate with C In . Differences between eGFR and C In were assessed. Moreover, we evaluated the concordance rates of the cases whose GFR was determined to be ≥ 70 mL/min/1.73 m 2 , which is the Japanese marginal donor criterion, presuming the participants of this study to be kidney donor candidates.
Statistical analysis
All obtained data were statistically analyzed. Continuous variables were presented as medians and ranges (minimum-maximum), and a Mann-Whitney U test or Wilcoxon signed-rank test was used to compare between groups. Categorized variables were presented as percentages, and a chi-squared test or a Fisher's exact test was used to detect between-group differences. SPSS software (ver. 22; IBM Corp., Armonk, NY USA) was used for these statistical analyses. Table 1 shows the characteristics of the 210 participants. Mean age was 52.5 years, and men accounted for 60% of all participants. Mean body surface area for men was 1.72 m 2 and for women was 1.50 m 2 . Median Cr level was 1.13 mg/dL, and median Cys level was 1.24 mg/L. Median level of excreted urine protein was 0.5 g/day. Median volume of urine Cr excretion was 1025 mg/day. Thirty-six participants were assessed as actual living kidney donor candidates. Although their body weights were significantly lower than all other participants, their serum albumin levels were significantly higher. Their Cr and Cys levels were significantly lower than all participants. In addition to these tendencies, their urinary protein excretion was lower.
Results
Participant characteristics
Comparison between C In and other kidney function estimation tests
Results of the comparison between C In and other kidney function estimation tests using all participant data are shown in Table 2 . Compared with C In , C Cr -estimated kidney function results were the highest among the results of all kidney function estimation tests. Kidney function estimated by eGFR Cys and eGFR-CKDEPI Cr was significantly higher than that estimated by C In . In contrast, kidney function estimated by eGFR Cr was significantly lower than that estimated by C In . Kidney function estimated by eGFR Cr+Cys and C In showed no significant difference.
To evaluate the accuracy of each test method, we calculated the percentage of estimates falling within ± 30% of mGFR (P30), the percentage falling within ± 10% of mGFR (P10), and the absolute error between C In and the other eGFR methods. eGFR Cr+Cys showed the highest accuracy for both P10 and P30 and the lowest error, whereas C Cr showed the lowest accuracy for P30 (57%). Figure 1 shows scatter plots for C In and other kidney function estimation models. Study participants' C In was widely distributed from chronic kidney disease (CKD) stage 1 to stage 5. Figure 1a shows the relationship between C In and C Cr . The correlation between C In and C Cr was determined to be good (r = 0.889), but the values of C Cr were greater than those of C In from low GFR to high GFR. This suggests that C Cr estimates higher kidney function, without regard to GFR level. The number of cases in which GFR was measured by C In to be ≥ 70 mL/min/1.73 m 2 was 81. However, the number of cases in which GFR was estimated by C Cr to be ≥ 70 mL/ min/1.73 m 2 increased to 100. Among these 100 cases, the number of cases in which the GFR measured by C In was < 70 mL/min/1.73 m 2 was 23. Therefore, 23% of candidates were incorrectly evaluated as adequate using C Cr despite the true GFR being inadequate for a living Figure 1b shows the relationship between C In and eGFR Cr . A good correlation was observed between C In and eGFR Cr (r = 0.888). The correlation between C In and eGFR Cr was mostly good in patients with GFR < 60 mL/min/1.73 m 2 , which was the definition of CKD, but eGFR Cr tended to underestimate kidney function in patients with functionally normal kidneys. If eGFR Cr was used to evaluate the donor adequacy of the participants in this study, kidney function was overestimated in 7/62 cases (11%) and underestimated in 12/81 cases (15%), compared to that estimated using C In . Figure 1c shows the relationship between C In and eGFR Cys . The relationship between C In and eGFR Cys displayed great variation, and the correlation between C In and eGFR Cys was worse than that between the other kidney function tests (r = 0.882). If eGFR Cys was used to evaluate the donor adequacy of the participants in this study, kidney function was overestimated in 15/84 cases (18%) and underestimated in 12/81 cases (15%), compared to that estimated using C In . Figure 1d shows the relationship between C In and eGFR Cr+Cys . The average of eGFRCr and eGFRCys improved the underestimation due to eGFRCr and the variation due to eGFRCys. The best correlation was observed between C In and eGFR Cr+Cys (r = 0.903). If eGFR Cr+Cys was used to evaluate donor adequacy of participants in this study, kidney function was overestimated in 7/77 cases (9%) and underestimated in 10/81 cases (12%), compared to that estimated using C In . Figure 1e shows the relationship between C In and eGFR-CKDEPI Cr . A good correlation was observed between C In and eGFR-CKDEPI Cr (r = 0.890). The accuracy of eGFR-CKDEPI Cr was mostly good for CKD, but eGFR-CKDEPI Cr tended to underestimate kidney function in patients with functionally normal kidneys. If eGFR-CKDEPI Cr was used to evaluate participant donor adequacy in this study, kidney function was overestimated in 8/81 cases (10%) and underestimated in 12/81 cases (16%), compared to that estimated using C In .
Evaluation of kidney donor eligibility data using each kidney function estimation test
Among the several kidney function estimation tests conducted in this study, CCr had the highest tendency to overestimate kidney function, and C Cr showed a tendency to estimate kidney function the highest.
Impact of sex on estimation accuracy
Some GFR estimation formulas use different coefficients in the case of a female, because males and females have different average body sizes and body components, such as muscle volume. Therefore, we investigated whether differences of sex affected relationships between (Fig. 2) . The results showed that females had greater a variation than males in each relationship. Especially in the relationship between C Cr and C In , females tended to present higher C Cr than C In as well as greater variation.
Impact of the amount of creatinine excretion on estimation accuracy
Because urine Cr excretion differed widely among participants, we checked whether GFR estimation accuracy is affected by urine Cr excretion. We divided participants into two groups with a median Cr excretion of 1025 mg/day and compared the two groups. Male sex was predominant and body surface area was significantly large in the high Cr excretion group. The relationships between C In and each GFR estimation method for each group are shown in Appendix A. Since C In was significantly different between the two groups, we evaluated accuracy by comparing errors between the GFR estimation methods and C In . The results are presented in Table 3 . The kidney function values were higher with C Cr than with C In , regardless of Cr excretion. eGFR Cr was significantly lower in the high Cr excretion group. Accuracy of eGFR Cys was not affected by Cr excretion. Errors between eGFR Cr+Cys and C In were small regardless of Cr excretion. eGFR-CKDEPI Cr was underestimated in the high Cr excretion group.
Evaluation in living kidney donor candidates
This study included participants with proteinuria or obviously low kidney function, who could not be considered originally as living kidney donors. Therefore, we performed a sensitivity analysis in only living kidney donor candidates (Fig. 3) . A total of 36 subjects were included. Median C Cr was 87.1 mL/min/1.73 m 2 , and median C In was 85.0 mL/min/1.73 m 2 . Median C Cr was significantly higher than that of C In in these donor candidates. In 15% of these cases, the levels were ≥ 70 mL/ min/1.73 m 2 when using C Cr , but the levels were < 70 mL/min/1.73 m 2 when using C In , illustrating how C Cr overestimates kidney function. Median eGFR Cr was 66.7 mL/min/1.73 m 2 , which was significantly lower than that using C In . Concerning the evaluation of living donor adequacy, kidney function was overestimated in 6% of cases and underestimated in 27% cases. Median eGFR Cys was 75.1 mL/min/1.73 m 2 , which showed no significant difference compared to C In . Concerning the evaluation of living donor adequacy, kidney function was overestimated in 10% of cases and underestimated in 10% of cases. Median eGFR Cr+Cys was 71.4 mL/min/1.73 m 2 , which presented no significant difference with C In . Overall, kidney function was overestimated in 5% of cases and underestimated in 18% of cases. Median eGFR-CKDEPI Cr was 75.6 mL/min/1.73 m 2 , which did not imply significant differences with C In . However, Continuous variables were presented as medians and ranges (minimum-maximum). Mann-Whitney U test was used to compare between groups. Categorized variables were presented as percentages and chi-squared tests were used to detect between-group difference. GFR glomerular filtration rate; eGFR estimated GFR based on Cr (creatinine) Cys (cystatin C), Cr + Cys (an average of Cr + Cys), or CKDEPI Cr (a Cr-based equation from The Chronic Kidney Disease Epidemiology Collaboration ([CKD-EPI]); C In inulin clearance; C Cr creatinine clearance; n.s. no significance concerning the evaluation of living donor adequacy, kidney function was overestimated in 11% and underestimated in 18% of cases. C Cr had the highest percentage in terms of overestimation of kidney function for classifying adequate donors in actual living kidney donor candidates.
Discussion
In this study, we investigated the relationships between mGFR using C In and several kidney function estimation tests and evaluated the impact of these tests in determining the adequacy for living kidney donors. Our findings reveal that C Cr overestimates kidney function the most when compared with eGFR Cr , eGFR Cys , eGFR Cr+Cys , and eGFR-CKDEPI. Estimated kidney function obtained using C Cr is not equal to mGFR. Therefore, there is a risk that living kidney donor candidates with insufficient kidney function are falsely evaluated as adequate for kidney donation when C Cr is used. A previous study reported that C Cr overestimated the GFR; especially in cases with low GFR, the C Cr showed a marked tendency to overestimate the GFR [10] . This phenomenon is thought to occur due to creatinine not only being filtrated through the glomeruli but also excreted by the renal tubules. As for estimating GFR using C Cr , the Japanese guidebook for CKD in 2012 described that C Cr was 30% higher than mGFR and needed to be multiplied by the coefficient 0.715 for converting to GFR [4] . According to this guidebook, the formula of GFR = 0.715 × C Cr can be established. Using this formula could decrease the overestimation using C Cr , but the Guidelines for Japanese Living Kidney Donors has not included this conversion [2] . Therefore, it is not known whether or not this converting formula is being used in the clinical setting. If this converting formula is applied to participants of this study, the number of cases of Figure 3 shows scatter plots for C In and other kidney function estimation models in living kidney donor candidates. a CIn and CCr, b CIn and eGFRCr, c CIn and eGFRCys, d CIn and eGFRCr+Cys, e CIn and eGFR-CKDEPICr. For reference, auxiliary line which equal to C In was presented. Abbreviations: GFR glomerular filtration rate; eGFR estimated GFR based on Cr (creatinine) Cys (cystatin C), Cr + Cys (an average of Cr + Cys), or CKDEPI Cr (a Cr-based equation from The Chronic Kidney Disease Epidemiology Collaboration ([CKD-EPI]); C In , inulin clearance; C Cr creatinine clearance overestimation decreased to 3/59 cases (5%). However, using that same converting formula, the number of cases of underestimation increased to 25/81 cases (31%). The coefficient 0.715 encouraged underestimation for donors in this study. The coefficient 0.715 could be too low for the normal GFR population, so further study is needed. Kidney donations from candidates with insufficient GFR could not only lead to poorer transplanted kidney function but this could also adversely affect the long-time prognosis of an altruistic kidney donor. Revision of the Japanese donor guidelines concerning acceptable estimation methods for GFR is thought to be needed based on the results of this study.
In this study, we revealed the differences among several kidney function estimation methods for the evaluation of the eligibility of potential donors. The tendency of eGFR Cr and eGFR-CKDEPI Cr was to underestimate kidney function and that of eGFR Cys was to overestimate kidney function. The method that most closely aligned with mGFR was eGFR Cr+Cys . The reason why Cr-based GFR estimation formulas such as eGFR Cr and eGFR-CKDEPI Cr underestimate kidney function could be due to the characteristics of Cr behavior, which are affected by muscle volume and food intake as well as glomerular filtration and tubular secretion. CKD patients whose data were used to create GFR estimation formulas, in general, have lower muscle volume and less food intake than a healthy population. Therefore, it has been reported that applying these equations to groups with high GFR could underestimate their renal function. Actually, errors between C In and eGFR Cr or eGFR-CKDEPI Cr were significantly large in high Cr excretion participants. Matsuo et al. reported the possibility that eGFR Cr might underestimate kidney function in the population with normal kidney function in a report introducing the Japanese GFR equation [6] . Several other studies concerning kidney function of living kidney donor candidates have presented that eGFR Cr was lower than mGFR, corroborating our findings in the current study [11] [12] [13] [14] . The risk of underestimation should be considered when healthcare professionals use Cr-based equations as a screening criterion for living kidney donors. Although eGFR-CKDEPI Cr was intended to increase the accuracy in the higher GFR population by using two types of estimation formulas depending on the Cr value, eGFR-CKDEPI Cr in this study showed no superiority over eGFR Cr , and eGFR-CKDEPI Cr showed a larger deviation from mGFR in the population with good kidney function. For Cys-based testing, eGFR Cys generally showed a higher eGFR value than mGFR, although eGFR Cys did show a more accurate GFR value in kidney donor candidates. However, it is recommended that other kidney function estimation tests be checked when applying estimation formulas to actual candidates, because the deviation of eGFR Cys was relatively large and it is known that Cys might be affected by thyroid function. eGFR Cr+Cys did show a value that was closer to mGFR than Cr-based equations and ameliorated the deviations that were shown by eGFR Cys . In fact, eGFR Cr+Cys showed the greatest accuracy of all equations investigated in this study. Even though eGFR can be easily checked by a single blood sampling, it is important to know the differences in characteristics between each equation for a more informed and accurate evaluation.
This study suggests that C Cr and each GFR estimation formula studied is less accurate in evaluating female participants. One of the reasons is that females, on average, have a significantly smaller body surface area than males. Individuals with smaller body surface areas show larger estimated values than their actual GFR due to the correction factor of 1.73 m 2 body surface area. This correction causes tendencies to deviate from mGFR in smaller subjects. If a female with a small body mass is being considered to be a potential living kidney donor candidate, the use of C Cr should be avoided for evaluating her kidney function.
This study showed that kidney function could be overestimated or underestimated to varying degrees irrespective of the kidney function estimation method. This finding suggests that it is insufficient to evaluate kidney function using only one estimation method. It is important to use a number of evaluation methods to determine the candidate's adequacy for donation. For example, it stands to reason that the average of eGFR Cr and eGFR Cys should be used for screening and that mGFR should be used for confirmation. The guidelines recommend C In and a radioisotope method for measuring GFR. A radioisotope method is relatively expensive and only limited facilities can perform this testing. Therefore, a more aggressive application of C In is desired. C In is one of the most reliable methods for measuring GFR and is considered to be the gold standard. C In requires no special equipment and can be performed at any facility. Because the C In measurement method is rather complex, few facilities are performing it currently. However, it is desirable to create an in-hospital system that can measure C In daily at any facility that performs kidney transplantation.
This study revealed that C Cr overestimates kidney function. Therefore, living kidney donors evaluated as adequate for donation using C Cr need long-term monitoring to determine whether or not their kidney function worsens after the kidney donation. In particular, as marginal donor cases determined by C Cr are considered to have a risk of worsening kidney function, these patients need closer and more long-term follow-up. If cases judged by C Cr as marginal donors do not show worsening kidney function through longitudinal observation, de-escalation of the Japanese criteria for living kidney donors might be possible. Longitudinal follow-up of post kidney transplant donors and accumulation of data are required to address this issue definitively.
This study has several limitations. First, it was conducted with data from a single center, and the collected data were obtained from patients visiting our hospital. Therefore, the results cannot be simply applied to living kidney donor candidates who belong to a super healthy population. Second, perfect urine collection is needed in the process of measuring C In , but residual urine volume in the bladder was not checked in this study. Other GFR affirming methods, such as the radioisotope method, were not conducted in this study because of its retrospective study design. Therefore, there might be some susceptibility to error in the value measured by C In . In addition, although it is known that Cys is affected by thyroid function, thyroid function could not be checked in all participants because of the retrospective study design. Therefore, this study may contain potential errors.
Conclusions
Kidney function estimated by C Cr is not equal to mGFR. When using C Cr as a kidney function estimation method to determine the adequacy of a living kidney donor, consideration that C Cr might overestimate kidney function is required. It is important to combine multiple eGFR values calculated by each equation to evaluate deviation. Particularly in the case of evaluating the adequacy of marginal donor, GFR estimated by C In should be required.
Appendix
Impact of creatinine excretion on estimation accuracy
Appendix shows scatter plots for C In and other kidney function estimation models dividing into Cr excretion amount. A; CIn and CCr, low Cr excretion group, B; CIn and CCr, high Cr excretion group, C; CIn and eGFRCr, low Cr excretion group, D; CIn and eGFRCr, high Cr excretion group, E; CIn and eGFRCys, low Cr excretion group, F; CIn and eGFRCys, high Cr excretion group, G; CIn and eGFRCr+Cys, low Cr excretion group, H; CIn and eGFRCr+Cys, high Cr excretion group, I; CIn and eGFR-CKDEPICr, low Cr excretion group, J; CIn and eGFR-CKDEPICr, high Cr excretion group. For reference, auxiliary line which equal to CIn was presented. For reference, auxiliary line which equal to C In was presented.
Abbreviations C Cr : Creatinine clearance; C In : Inulin clearance; CKD: Chronic kidney disease; CKD-EPI: The Chronic Kidney Disease Epidemiology Collaboration; Cr: Creatinine; Cys: Cystatin C; eGFR: Estimated GFR; eGFR-CKDEPI Cr : eGFR as calculated using the Cr-based CKD-EPI equation; eGFR Cr : eGFR as measured by creatinine; eGFR Cr+Cys : Average of eGFR Cr and eGFR Cys ; eGFR Cys : eGFR as measured by cystatin C; GFR: Glomerular filtration rate; In: Inulin; mGFR: Measured GFR
